Financials data is unavailable for this security.
View more
Year on year Nakanishi Inc grew revenues 22.64% from 48.67bn to 59.69bn while net income improved 83.10% from 12.47bn to 22.84bn.
Gross margin | 56.75% |
---|---|
Net profit margin | 11.36% |
Operating margin | 18.24% |
Return on assets | 6.00% |
---|---|
Return on equity | 7.32% |
Return on investment | 7.06% |
More ▼
Cash flow in JPYView more
In 2023, cash reserves at Nakanishi Inc fell by 5.68bn. However, the company earned 8.63bn from its operations for a Cash Flow Margin of 14.46%. In addition the company generated 3.41bn cash from financing while 19.15bn was spent on investing.
Cash flow per share | 165.90 |
---|---|
Price/Cash flow per share | 16.60 |
Book value per share | 1,373.41 |
---|---|
Tangible book value per share | 938.73 |
More ▼
Balance sheet in JPYView more
Current ratio | 3.14 |
---|---|
Quick ratio | 2.08 |
Total debt/total equity | 0.1481 |
---|---|
Total debt/total capital | 0.129 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 8.70% and 84.20%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is above the industry average.
Div yield(5 year avg) | 1.66% |
---|---|
Div growth rate (5 year) | 12.30% |
Payout ratio (TTM) | 51.74% |
EPS growth(5 years) | 25.05 |
---|---|
EPS (TTM) vs TTM 1 year ago | -65.02 |
More ▼